Cargando…

Who Modifies the Modifiers: A High-Resolution View of the Genetic Modifiers of Cystic Fibrosis

Detalles Bibliográficos
Autores principales:	Kalra, Sean, Cho, Michael H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2023
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595439/ https://www.ncbi.nlm.nih.gov/pubmed/36961916 http://dx.doi.org/10.1164/rccm.202303-0468ED

Ejemplares similares

Genetic Modifiers of Cystic Fibrosis–Related Diabetes
por: Blackman, Scott M., et al.
Publicado: (2013)

Modifier Factors of Cystic Fibrosis Phenotypes: A Focus on Modifier Genes
por: Mésinèle, Julie, et al.
Publicado: (2022)

Modifier genes and variation in cystic fibrosis
por: Drumm, Mitchell L
Publicado: (2001)

Genetic Modifying Factors of Cystic Fibrosis Phenotype: A Challenge for Modern Medicine
por: Butnariu, Lăcrămioara Ionela, et al.
Publicado: (2021)

The role of genetic modifiers, inflammation and CFTR in the pathogenesis of Cystic fibrosis related diabetes
por: Hasan, Sana, et al.
Publicado: (2021)

Disease-modifying genes and monogenic disorders: experience in cystic fibrosis
por: Gallati, Sabina
Publicado: (2014)

Immunomodulatory function of the cystic fibrosis modifier gene BPIFA1
por: Saferali, Aabida, et al.
Publicado: (2020)

Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci
por: Gong, Jiafen, et al.
Publicado: (2019)

Antibiotic resistance and genetically modified plants
por: Midtvedt, Tore
Publicado: (2014)

Variation in MSRA Modifies Risk of Neonatal Intestinal Obstruction in Cystic Fibrosis
por: Henderson, Lindsay B., et al.
Publicado: (2012)

FUNCTIONAL PERFORMANCE IN THE MODIFIED SHUTTLE TEST IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS
por: Leite, Luanna Rodrigues, et al.
Publicado: (2020)

Antibacterial Effects of Bicarbonate in Media Modified to Mimic Cystic Fibrosis Sputum
por: Jaikumpun, Pongsiri, et al.
Publicado: (2020)

Editorial: Mechanisms of Novel Drugs and Gene Modifiers in the Treatment of Cystic Fibrosis
por: Veit, Guido, et al.
Publicado: (2022)

Histo-Blood Group Gene Polymorphisms as Potential Genetic Modifiers of Infection and Cystic Fibrosis Lung Disease Severity
por: Taylor-Cousar, Jennifer L., et al.
Publicado: (2009)

Potential genetic modifiers of the cystic fibrosis intestinal inflammatory phenotype on mouse chromosomes 1, 9, and 10
por: Norkina, Oxana, et al.
Publicado: (2005)

Beta-defensin genomic copy number is not a modifier locus for cystic fibrosis
por: Hollox, Edward J, et al.
Publicado: (2005)

Control Using Genetically Modified Insects Poses Problems for Regulators
por: Lehane, Michael J., et al.
Publicado: (2012)

Modified forced expiration technique using expiratory resistance in adults with cystic fibrosis
por: Watson, Kathryn, et al.
Publicado: (2023)

DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis
por: Magalhães, Milena, et al.
Publicado: (2017)

In silico search for modifier genes associated with pancreatic and liver disease in Cystic Fibrosis
por: Trouvé, Pascal, et al.
Publicado: (2017)

Cystic Fibrosis Lung Disease Modifiers and Their Relevance in the New Era of Precision Medicine
por: Sepahzad, Afsoon, et al.
Publicado: (2021)

Mendel in the kitchen: a scientist's view of genetically modified foods
por: Fedoroff, Nina V, et al.
Publicado: (2004)

The Relation of the Non-modifiable (Destiny) and Modifiable (Free Will) Factors in Metabolic Derangements
por: Joshi, Ameya S., et al.
Publicado: (2018)

TAS2R38 is a novel modifier gene in patients with cystic fibrosis
por: Castaldo, Alice, et al.
Publicado: (2020)

G-CSF and GM-CSF Modify Neutrophil Functions at Concentrations found in Cystic Fibrosis
por: Castellani, Stefano, et al.
Publicado: (2019)

Inorganic-Nanoparticle Modified Polymers
por: Díez-Pascual, Ana M.
Publicado: (2022)

CLC-2 single nucleotide polymorphisms (SNPs) as potential modifiers of cystic fibrosis disease severity
por: Blaisdell, Carol J, et al.
Publicado: (2004)

SLC26A9 as a Potential Modifier and Therapeutic Target in Cystic Fibrosis Lung Disease
por: Gorrieri, Giulia, et al.
Publicado: (2022)

Genetic modifiers of p53: opportunities for breast cancer therapies
por: Majhi, Prabin Dhangada, et al.
Publicado: (2023)

Histone Acetylation and Modifiers in Renal Fibrosis
por: Shen, Fengchen, et al.
Publicado: (2022)

A regulatory SNP modifies cystic fibrosis by disrupting NFκB complex binding on FAS
por: Awah, Chidiebere U, et al.
Publicado: (2015)

SLC6A14 Is a Genetic Modifier of Cystic Fibrosis That Regulates Pseudomonas aeruginosa Attachment to Human Bronchial Epithelial Cells
por: Di Paola, Michelle, et al.
Publicado: (2017)

Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis
por: Haque, A. K. M. Ashiqul, et al.
Publicado: (2018)

Cystic fibrosis revisited
por: Kulkarni, H, et al.
Publicado: (2019)

Imaging coronary sinus in modified bicaval view
por: Raut, Monish S., et al.
Publicado: (2015)

Carcinoma-derived exosomes modify microenvironment
por: Maitland, Norman J.
Publicado: (2015)

Redox unbalance modifies neurogenic potential
por: Raciti, Marilena, et al.
Publicado: (2016)

Activity modifies adult brain maturity
por: Kobayashi, Katsunori
Publicado: (2017)

Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics
por: Strug, Lisa J., et al.
Publicado: (2016)

Modified Chrispin-Norman chest radiography score for cystic fibrosis: observer agreement and correlation with lung function
por: de Jong, P. A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5j1ken96qk97hd1bn02v6388b2